WebApr 14, 2024 · MOR Komplette Morphosys Aktien News ☑ Mit Realtime Kurs und Prognose der Morphosys Aktie Analysiere mit wallstreet:online DAX 15.819,00 +0,33 % Gold 2.004,25-1,75 % Öl (Brent) 86,44 +0,20 % ... WebApr 6, 2024 · 10% least volatile stocks in DE Market. 2.7%. Stable Share Price: MOR is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 7% a week. Volatility Over Time: MOR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
Morphosys Ag (MOR) Price & News - Google Finance
WebApr 12, 2024 · EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Apr 05 2024; EQS-News: MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2024 Apr 04 2024; … WebApr 12, 2024 · Realtime-Aktienkurs und Xetra-Orderbuch von MORPHOSYS AG. Aktuelle Kurse zu WKN 663200 und Ticker MOR ... Morphosys: Hoffnung auf Krebsmedikament … theatre de pierres
MorphoSys A global biopharmaceutical company
WebView today's MorphoSys AG ADR stock price and latest MOR news and analysis. Create real-time notifications to follow any changes in the live stock price. WebMar 23, 2024 · MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2024. Read more. 03/24/2024. WebApr 13, 2024 · Financial Performance. In 2024, MorphoSys AG's revenue was $278.27 million, an increase of 54.93% compared to the previous year's $179.61 million. Losses … the gotcha belt reviews